Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
L-amino acid deaminase (L-AAD) is a membrane-bound, flavin adenine dinucleotide (FAD)-containing enzyme that catalyzes the oxidative deamination of L-amino acids to produce their corresponding α-keto acids and ammonia. This reaction is significant in both metabolic pathways and industrial biocatalysis due to its broad substrate specificity and efficient conversion without generating hydrogen peroxide as a byproduct. Found in various organisms including bacteria (*Proteus*, *Providencia*, *Morganella* species), fungi, fish skin/gill secretions, insects, and snake venom. Plays roles in amino acid catabolism for energy production or biosynthesis of secondary metabolites.
Oxidative deamination of L-amino acids
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on L-amino acid deaminase (L-AAD).